14-3-3/HIP-55 complex attenuates cardiomyocyte apoptosis

Area of Science:

• Cardiology
• Molecular Biology
• Cell Death Research

Background:

• Myocardial infarction (MI) is a major cause of global mortality, primarily due to cardiomyocyte death.
• Early endogenous cardioprotection is critical for limiting infarct size and improving patient outcomes.
• 14-3-3 proteins are known to be involved in cardiomyocyte survival, but the underlying mechanisms are not fully understood.

Purpose of the Study:

• To elucidate the mechanism by which 14-3-3 proteins protect cardiomyocytes against MI-induced death.
• To identify the role of HIP-55 protein in 14-3-3 mediated cardioprotection.
• To investigate the signaling pathway involving RSK1, 14-3-3, and HIP-55 in response to cardiac injury.

Main Methods:

• Investigated the interaction between 14-3-3 and HIP-55 in cardiomyocytes subjected to MI injury.
• Utilized in vitro and in vivo models of myocardial infarction.
• Employed RSK1 kinase assays and site-directed mutagenesis (S269A/T291A) of HIP-55 to study phosphorylation-dependent complex formation and its functional consequences.
• Assessed cardiomyocyte apoptosis and the ASK1 apoptotic pathway.

Main Results:

• Identified a novel complex formed between 14-3-3 and HIP-55 that suppresses MI-induced cardiomyocyte death.
• Demonstrated that HIP-55 confers protection against MI-induced cardiomyocyte apoptosis.
• Showed that RSK1 phosphorylates HIP-55 at S269/T291 sites, promoting 14-3-3/HIP-55 complex formation and inhibiting the ASK1 apoptotic pathway.
• Mutated HIP-55 (S269A/T291A), unable to form the complex, lost its protective effect against MI-induced apoptosis.

Conclusions:

• The 14-3-3/HIP-55 complex is a key mediator of cardiomyocyte survival following myocardial infarction.
• RSK1-mediated phosphorylation of HIP-55 is essential for the formation of this protective complex.
• Targeting the 14-3-3/HIP-55 interaction presents a promising therapeutic strategy for mitigating cardiac damage in acute myocardial injury.